___

• Buckley BM. Lipids and Stroke. Br J Diab & Vas Dis 2003;3:1706.
• Gariballa SE, Hutchin TP, Sidair AJ. Antioxident capacity after acute ischemic stroke. QIM 2002;95:68590.
• Denti L, Cechetti A, Annoni V, Franceska M, Ablondi F, et al. The role of lipid profile in determining the risk of ischemic stroke in the elderly: a case control study. Arch GeroontolGeriatr 2003;37:5162.
• Tirschwell DL, Smith NL, Heckbert SR, Lamaitre RN, Longstr eth WT, etal. Association of cholesterol with stroke risk varies in stroke subtypes and patients subgroups. Neurology 2004;23:186875.
• Muralikrishna A, Dibhatie R, Hetcher JF. Phospholipase A2, reactive oxygen species and lipid Peroxidation in cerebral isc hemia. Free Radic Biol Med 2006;40:37687.
• Polidori MC, Frei B, Chimbini A, Nelles G, Rordorf G, Kearey JF,et al. Increased plasma levels of lipid hydroxyperoxidase in patients with ischemic stroke. Free Radic Biol Med 1998;25:5617.
• Uno M, Kitazato KT, Ni shi K, Itabe H, Nagahiro S. Raised plasmaoxidized LDL in acute cerebral infarction. J Neurol Neurosurg Psychiatry 2003;74:3127.
• Cherubini A, Ruggiero C, Polidori MC, Mecocci P. Potential markers of oxidative stress on stroke. Free Radic Biol Med 2005;39:84152.
• Leinonen JS, Ahonen JP, Loennrot K, Jenkonen M, Destider P, Moinar G, et al. Plasma antioxidant capacity is associated with high lesion volume and neurological impairment in stroke. Stroke 2000;31:339.
• Watson BD. Evaluation of the concomitance lipi d Peroxidation in experimental model of cerebral ischemia and stroke. Prog Brain Res 1993;96:6995.
• Ferriti G, Bacchetti T, Masciangelo S, Nanetti L, Mazzanti L, Sivestrini M, et al. Lipid Peroxidation in stroke patients Clin Chem Lab Med 2008;46(1):11317.
• Yildirim A, Kotan D, Yildirim S, Aygol R, Akcay F. Increased lipid Peroxidation and decreased antioxidant response in serum and cerebrospinal fluid in acute ischemic stroke. Turk J Med Sci 2007;37(2):7581.
• Bhattachaejee J, Srivastava DK. Serum Malondial dehyde (MDA) in relation to lipidemic status and atherogenic index. Ind J Clin BioChem 1993;8(1):1215.
• Lawrence HP. Salivary markers of systemic disease: Non invasive diagnosis of disease and monitoring of general health. J Can Dent Assoc 2002;68(3):170 -4.
• Lu Y, Bently G, Gann P, Hodgesk K. Salivary estradiol and progesterone levels in conception and nonconception cycle in women: Evaluation of a new assay for salivary estradiol. Fertility & Sterility 1999;71(5):86368.
• Karajalainen S, Sewan L, Soderling E , Larsson B, Johansson I, et al. Salivary cholesterol of healthy adults in relation to serum cholesterol concentration and oral health. J Dent Res 1997;76:163743.
• Buege JA, Aust SD. Microsomal lipid Peroxidation. Methods Enzymol 1978;52:302310.
• Richmond W. Preparation and properties of a cholesterol oxidase from Nocardia species and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 1973;19:13506.
• Fossati P, Prencipe L. Serum triglycerides determined calorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982;28:207780.
• Warnick GR, Mayfield C, Benderson J, Chen JS, Albers JJ. HDL -cholesterol quantification by phosphotungstate/MgCl 2 and dextran sulfate Mn +2
• Friedwald WT, Levy RI, Fredrickson D. Estimation of the concentration of LDLC in plasma without the use of preoperative ultracentrifuge. Clin Chem 1972;18(6):494515. polyethylene glycol precipitation , both with enzy matic cholesterol assay compared with the lipid research clinic method. Am J Clin Pathol 1982;78:71823.
• Wang O, Tang XN, Yenari MA. The inflammatory response in stroke. J Neuroimmunol 2007;184:5368.
• Hermes -Lima M, Willmore WG, Story KB. Quantification of Lipid Peroxidation in Tissue Extracts Based on Fe (III) Xylenol Orange Complex Formation. Free Radic Biol Med 1995;19: 271280.
• Draper HH, Squires EJ, Mahmoodi H, Wu J, Agarwal S, Hadley M . 25. Sakamoto A, Ohnishi ST, Ohnishi T & Ogawa R. Relationship between free radical production and lipid peroxidation during ischemia -reperfusion injury in rat brain. Brain Res 1991;554: 186 −192. A Comparative Evaluation of Thiobarbituric Acid Methods for the Determination of Malondialdehyde in Biological Materials.
• Sharpe, P.C., Mulholland, C. & Trinick, T. Ascorbate and malondialdehyde in stroke patients. Ir J Med Sci 1994; 163: 488491.
• Atiyah KM, Al -Rawi NH. Evaluation of Salivary and Serum Oxidative Stress and Neuronal Damage Markers as Potential Para meters in Prediction of Ischemic Stroke from StrokeRelated Risk Factors. Ph.D Thesis. University of Baghdad.
• Sacco RL, Bensen RT, Karagman DE. Highdensity lipoprotein cholesterol and ischemic stroke in the elderly. The Northern Manhattan Stroke study. JA MA 2001; 285:27292735.
• Benfante R, Yano K, Hwang LJ, Curb JD, Kagan A, Ross W. Elevated serum cholesterol is a risk factor for both coronary heart diseases and thromboembolic stroke in Hawaiian Japanese men. Implications of shared risk. Stroke 1994;25:81420.
• Di Mascio R, Marchioli R, Vitullo F, Di Pasquale A, Cavasinni L, Tognoni G. Serum cholesterol and risk of ischemic stroke: results of a case control study. On behalf of PROGETTO3A investigators. Prev Med 1995; 24:124133.
• Ebrahim S, Sung J, S ong YM, Ferrer RL, Lawlor DA, Davey Smith G. Serum cholesterol, hemorrhagic stroke, ischemic stroke and myocardial infarction:Korean National Health System Prospective Cohort Study. BMJ 2006:333:22.
• Zhang X, Patel A, Horibe H et al. Cholestrol, Coronary heart disease and stroke in the Asia Pacific region. Int J Epidemiol 2003; 32:56372.
• Kagan A, Papper JS, Rhoods GG. Factors related to stroke incidence in Hawaii Japanese men. The Honolulu Heart study. Stroke 1980; 11:1421.
• Prospective studies collaboration. Cholesterol, diastolic blood pressure and stroke: 13,000 strokes in 450,000 people cohorts. Lancet 1995; 346:164753.
• Bowman TS, Sesso HD, Ma J, et al. cholesterol and risk of ischemic stroke. Stroke 2003; 34:293034.
• Shahar E, Chambles LE, ras mond WD, Boland LL, Ballantyne CM, et al. Plasma lipid profile and incident ischemic stroke: The Atherosclerosis Risk in Communities (ARIC) study. Stroke 2003; 34:62330.
• Gorelick PB, Mazzone T. Plasma lipids and stroke. J Cardiovas Risk 1999; 6:21721. ( s)
• Gordon DJ and Rifkind BM. Highdensity lipoproteins: The clinical implication of recent studies. N Eng J Med 1989; 321:131116.
• Oizilbash N, Jones L, Warlow C, Mann J. Fibrinogen and lipid concentrations as risk factors for transient ischemic attacks and minor ischemic stroke. BMJ 1991; 303:605609.
• Sridharan R. ris k factors for ischemic stroke: A case control analysis. Neuroepidemiol 1992; 11:2430.
• Bihari -Varga M, Szekely J, Gruber E. Plasma high density lipoproteins in coronary, cerebral and peripheral vascular disease: The influence in coronary risk factors. At hersclerosis 1981; 40:33745.
• Koren Morag N, Tanne D, Gralf E, Goldbourt U. low and high density lipoprotein cholesterol and ischemic cerebro vascular diseases: the Bezafibrate infarction prevention registry. Arch Intern Med 2002; 162:99399.
• Salonen JT and Puska P.Relation of serum cholesterol and triglycerides to the risk of acute MI, cerebral stroke and death in eastern Finnish male population. Int J Epidemiol 1982; 12(1):2631.
• Kurth T, Evert BM, Buring JE, Kase CS, Ridker PM, Gaziano JM. Lipid level s and the risk of ischemic in women. Neurology 2007; 68:55662.
• Gaziano JM, Buring JE, Breslow JL, et al. moderate alcohol intake, increased levels of high -density lipoproteins and its subfractions, and decreased risk of myocardial infarction. N Eng J Med 1993; 329:182934.
• Ritschel WA, Thompson GA. Monitoring of drug concentrations in saliva: a non invasive pharmacokinetic procedure. Methods and findings in Experimental and Clini cal Pharmacology 1983; 5:51125.